Self-monitoring of blood glucose for patients with diabetes on insulin therapy is considered an essential part of management. However, for most patients with type 2 diabetes not using insulin, frequent monitoring of blood sugar levels using blood glucose test strips (BGTS) has not been found to be clinically beneficial and may lead to decreased quality of life and well-being.
The ODPRN has conducted multiple studies on self-monitoring of blood glucose levels (SMBG) primarily focusing on the impact of BGTS quantity limits on utilization, costs and patient outcomes.
Provincial governments across Canada have implemented blood glucose test strip (BGTS) quantity limits to encourage proper testing practices for optimal patient outcomes. The ODPRN has developed a provincial list of implementation details for each province as of May 2017.
Access the list here
All Research on Self-Monitoring of Blood Glucose